*Optimal dilutions/concentrations should be determined by the researcher.
Not tested in other applications.
H1299 , C2C12 , C2C12+AEA10mM , PC-12
Bovine, Chicken(>80% identity)
0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
1mg/ml(Please refer to the vial label for the specific concentration.)
Recombinant protein encompassing a sequence within the center region of human PI3K p110 beta. The exact sequence is proprietary.
Purified by antigen-affinity chromatography.
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
DKFZp779K1237 antibody, MGC133043 antibody, P110BETA antibody, PI3K antibody, PI3KBETA antibody, PIK3C1 antibody, PIK3CB antibody, ptdIns-3-kinase subunit beta antibody, PtdIns-3-kinase p110 antibody, PI3K-beta antibody, PI3-kinase p110 subunit beta antibody, PI3-kinase subunit beta antibody, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform antibody, phosphatidylinositol-4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta antibody, ptdIns-3-kinase subunit p110-beta antibody, phosphoinositide-3-kinase, catalytic, beta polypeptide antibody
Phosphoinositide 3-kinases (PI3Ks) phosphorylate the 3-prime OH position of the inositol ring of inositol lipids. They have been implicated as participants in signaling pathways regulating cell growth by virtue of their activation in response to various mitogenic stimuli. PI3Ks are composed of a 110-kD catalytic subunit, such as PIK3CB, and an 85-kD adaptor subunit (Hu et al., 1993 [PubMed 8246984]).[supplied by OMIM]